Tasker Sybil 4
4 · Altimmune, Inc. · Filed Sep 26, 2017
Insider Transaction Report
Form 4
Tasker Sybil
Chief Medical Officer
Transactions
- Award
Stock Options (option to buy)
2017-09-22+50,000→ 50,000 totalExercise: $2.48Exp: 2027-09-22→ Common Stock, par value $0.0001 (50,000 underlying)
Footnotes (1)
- [F1]On the first anniversary of the date of grant, 25% of the unvested portion of the option will become vested and exercisable, and the aggregate remaining unvested portion will vest and become exercisable in equal monthly installments over the 36-month period following such anniversary date.